11.55 USD
▼-0.36-3.02%
盘后 11.70 +1.30%
2026-09-15
市值
$9.98B
市盈率
28.51
EPS
0.42
股息率
0.56%
52 周区间
11.36 – 15.67
成交量
4.23M
Beta
0.24
目标价
13.38
52W 低 11.3652W 高 15.67
价格走势
公司简介
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as ...
关联新闻
- India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
Dr Reddy's Laboratories said on Friday it signed a deal with Takeda Pharmaceutical Company for the promotion and distribution of the Qdenga dengue vaccine in India.